Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A McKinnell

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Journal of Clinical Microbiology|January 30, 2016
Correction for Humphries and McKinnell, Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant EnterobacteriaceaeRomney M Humphries, James A McKinnell
Journal of Clinical Microbiology|October 16, 2015
Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant EnterobacteriaceaeRomney M Humphries, James A McKinnell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2015
Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical ExperienceJames A McKinnell, Cesar A Arias
Current Opinion in HIV and AIDS|January 6, 2010
Novel drug classes: entry inhibitors [enfuvirtide, chemokine (C-C motif) receptor 5 antagonists]James A McKinnell, Michael S Saag
Clinics in Chest Medicine|April 21, 2009
Blastomycosis: new insights into diagnosis, prevention, and treatmentJames A McKinnell, Peter G Pappas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2014
Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapyRavina Kullar, James A McKinnell, George Sakoulas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Reply to Eschenauer et alRavina Kullar, James A McKinnell, George Sakoulas
The New England Journal of Medicine|May 30, 2019
Postdischarge Infection Risk among MRSA Carriers. ReplySusan S Huang, James A McKinnell, Loren G Miller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2011
Daily cranberry prophylaxis to prevent recurrent urinary tract infections may be beneficial in some populations of womenSamantha J Eells, James A McKinnell, Loren G Miller
Infection Control and Hospital Epidemiology|April 5, 2011
Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgeryLoren G Miller, James A McKinnell, Michael E Vollmer, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Journal of Clinical Microbiology|January 30, 2016
Correction for Humphries and McKinnell, Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant EnterobacteriaceaeRomney M Humphries, James A McKinnell
Journal of Clinical Microbiology|October 16, 2015
Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant EnterobacteriaceaeRomney M Humphries, James A McKinnell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2015
Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical ExperienceJames A McKinnell, Cesar A Arias
Current Opinion in HIV and AIDS|January 6, 2010
Novel drug classes: entry inhibitors [enfuvirtide, chemokine (C-C motif) receptor 5 antagonists]James A McKinnell, Michael S Saag
Clinics in Chest Medicine|April 21, 2009
Blastomycosis: new insights into diagnosis, prevention, and treatmentJames A McKinnell, Peter G Pappas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2014
Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapyRavina Kullar, James A McKinnell, George Sakoulas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Reply to Eschenauer et alRavina Kullar, James A McKinnell, George Sakoulas
The New England Journal of Medicine|May 30, 2019
Postdischarge Infection Risk among MRSA Carriers. ReplySusan S Huang, James A McKinnell, Loren G Miller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2011
Daily cranberry prophylaxis to prevent recurrent urinary tract infections may be beneficial in some populations of womenSamantha J Eells, James A McKinnell, Loren G Miller
Infection Control and Hospital Epidemiology|April 5, 2011
Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgeryLoren G Miller, James A McKinnell, Michael E Vollmer, et al.
Pageof 8